TriMaximize all 3 presented Posters

Exacerbation Reduction and Improved Quality of Life in Asthma with Extrafine Formulation Single-Inhaler Triple Therapy (efSITT): Six-Month Results of the TriMaximizeStudy

Impact of Extrafine Formulation Single-Inhaler Triple Therapy on Asthma Control and Treatment Adherence after Six Months of Treatment in Patients with Asthma -TriMaximize Study

Improvement in Lung Function after Six Months of Treatment with Extrafine Formulation Single-Inhaler Triple Therapy (efSITT) in Patients with Asthma -TriMaximize Study